The ministry has asked 44 pharmaceutical companies, including global drug majors such as Eli Lilly, Novartis, Pfizer, Bayer, Merck, Johnson & Johnson and Sanofi Aventis, to explain why they have not given the compensation, which is mandatory under the current drug laws.
While Pakistan has been showing considerable interest in having a bilateral trade deal with India that would help them access the country's booming markets, India has stated this can only become a possibility only when it recognises India as their non-discriminatory trading partner, commerce secretary Rahul Khullar told in an interview.
The central government is likely to notify the merger and acquisition (M&A) rules meant to operationalise M&A provisions prescribed under the Competition Act, 2002 by mid-April.
The India-Asean free trade agreement (FTA) in merchandise goods has failed to realise its full potential, even as the deal was implemented in January 2010 to facilitate greater trade in the region. As a result, reduction of duties on several products might get delayed.
European countries are trying to woo back the Indian customers they had lost following seizure of drug consignments by Customs authorities of several European Union members.
The US has emphasised on the need for an "ambitious and balanced outcome", even as the World Trade Organization (WTO) is gearing up to circulate another set of texts to push all its 153 members to wrap up the Doha Round of global trade talks by the end of this year.
FDI is essentially long-term investments that come with added benefits such as better technology, management and marketing assistance, says the study.
The move comes after international studies revealed that Gatifloxacin posed 17 times higher risk of developing serious hyperglycemia than other antibiotics in elderly patients.
The revised version of the FDI policy, which will be released on March 31, is expected to do away with Press Note 1, 2005, to bring in the above-mentioned change.
A lot of global products are yet to be launched in the country. In the last eight months, we have launched six products from our global product portfolio.
Under the services sector, India had been demanding greater opening, so that more professionals like doctors, nurses, chefs, accountants get greater job opportunities.
Ministry will give relief to exporters through a mechanism that will enable a timely refund of credit balance and time-bound refund of additional duty of customs.
India and the US are set to address some of the prickly issues that have acted as major irritants in the commercial relations between both countries recently, to ensure greater flow of trade and investment.
India may have to abide by a series of international standards and regulatory practices in the healthcare sector, if it agrees to some proposals that are part of the ongoing India-EU Free Trade Agreement (FTA) negotiations.
If implemented, the measure would have choked the availability of funds for real estate firms and infrastructure companies, which typically have several layered subsidiaries.
We welcome all companies from India to come and invest and do business there. We have almost no restrictions in any sector at all. However, we expect similar reciprocity in India for our apples, pistachios, helicopters, and disaster relief materials, besides other products. We do not restrict such items from entering the US markets.
The letters were meant to assess if there had been any professional misconduct by any auditors of Reliance Infra and Reliance National Resources Ltd that led to the alleged misrepresentation of investments by these companies.
The ministry of corporate affairs - under new minister Murli Deora - has reopened for further investigation the cases of two companies allegedly involved in the unravelling 2G scam. A senior official said that the ministry was currently probing Swan Telecom and Loop Telecom.
The finance ministry said it would wait for RBI guidelines, a development which will provide much relief to ICICI Bank and HDFC Bank. Both are already known as Foreign Owned Indians Controlled entities, after foreign investment in them rose much above 50 per cent, following new norms of calculations by the commerce ministry.
Daiichi Sankyo, Japan's third-largest drug maker, has transferred six of its early drug discovery programmes in inflammatory and infectious diseases from its Japanese research & development (R&D) facilities to India.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances